Journal of Southern Medical University ›› 2006, Vol. 26 ›› Issue (05): 689-691.

Previous Articles     Next Articles

Efficacy of Avastin in combination with irinotecan for metastatic colorectal cancer

ZHENG Hang,CHEN Jin-zhang,LIAO Wang-jun,LUO Rong-cheng Center of Oncology,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China   

  1. 南方医科大学南方医院肿瘤中心; 南方医科大学南方医院肿瘤中心 广东广州510515; 广东广州510515;
  • Online:2006-05-20 Published:2006-05-20

Abstract: Objective To evaluate the efficacy of Avastin in combination with irinotecan for metastatic colorectal cancer.Methods Ninety patients were randomly divided into 3 equal groups to receive Avastin plus irinotecan(group A),FOLFIRI(group B)and FOLFOX7(group C)for two cycles,respectively.The response rate and changes in tumor maker levels were observed.Results The tumor response rate was 43.3% in group A,27.7% in group B and 30.0% in group C.The disease control rate(complete response+partial response+stable disease)was 80% in group A,53.3% in group B and 50.0% in group C.Obvious changes in tumor marker levels were observed in the 3 groups after treatment,which were most conspicuous in group A(P<0.05).Conclusion The addition of Avastin to irinotecan chemotherapy results in significant improvement of clinical efficacy in patients with metastatic colorectal cancer. 

CLC Number: